BioAces (Shanghai) Life Science Co., Ltd. established in 2020, is a high-tech enterprise that integrates the research, development, production, sales, and service of life science instruments.
The company has a technical team with expertise in multiple interdisciplinary fields, and the core team members are from various departments of Peking University. We have submitted and obtained over 20 national invention and international PCT patents.
The company focuses on cell analysis and monitoring technologies for biological reactions in the field of life sciences. The company aspires to be an innovator and pioneer in live cell imaging and microfluidic chip technologies. Our team independently developed system is based on a microfluidic technology platform, utilizing cutting-edge optical analysis techniques and integrating artificial intelligence algorithms such as machine learning and deep learning. This enables multi-dimensional data modeling and visualization of the dynamic processes of live cells in biological reactions.
The core technologies of the company's products from the transformation of years of independent scientific research achievements. The product line includes real-time multimodal imaging of live cells, flow cytometry analysis, and high-content imaging analysis equipment. These products find wide applications in upstream process development of biologics, such as vaccines, ADC, mAbs, and CGT.
Since its establishment four years ago, the company has already launched two products into the market, with more in the pipeline. In December 2023, the company was awarded the title of high-tech enterprise.
Continuously focusing on cell analysis and monitoring technologies in the field of life sciences, the company aims to facilitate the intelligent, automated, and simplified transformation of biopharmaceutical processes, empowering the high-quality development of the biopharmaceutical industry.
As a fully automatic intelligent cell analyzer,the CytScop®Pro utilizes AOPI dual fluorescence and Trypan Blue Dye Exclusion method to determine cell viability.Equipped with brightfield and fluorescence wide-field microscopy optical systems and disposable microfluidic consumables,incorporates high-precision cell recognition algorithms. Coupled with fully automatic, high-throughput operation systems, CytScop®Pro achieves accurate, stable, efficient, economical, and standardized analysis of cell counting and viability in the field of biopharmaceutical.
The CytScop® Mini intelligent cell analyzer utilizes AOPI dual fluorescence and Trypan Blue Dye Exclusion method, as well as unique bright field and fluorescence micro-optical system with wide field of view. Combined with disposable microfluidic consumables and a high precision cell identification algorithm, the CytScop® Mini is capable of achieving effective and stable measurement of cell count, cell viability, cell concentration, and growth curve.
Miniaturized body also allows for cell count analysis to be conducted anywhere and at any time. Experimental data can be transmitted to the cloud server through Bluetooth or directly, removing the constraints of time and space. Multiple innovative designs and cutting-edge technology integration ensure more accurate cell counting results while providing a comfortable operating experience.
Wechat
